Official Publications Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
147.68 USD | +0.16% |
|
-2.28% | -20.05% |
Official Publications
1st quarter results | 05-06 | CO |
SEC Filing 10Q-1 | 05-06 | CO |
SEC Filing 8K | 05-06 | CO |
Proxy Statments | 04-01 | CO |
Slide show results | 02-18 | CO |
Annual results | 02-18 | CO |
SEC Filing 10K | 02-18 | CO |
SEC Filing 8K | 02-18 | CO |
Slide show Q3 | 11-05 | CO |
SEC Filing 10Q-3 | 11-05 | CO |
3rd quarter results | 11-05 | CO |
SEC Filing 8K | 11-05 | CO |
SEC Filing 8K | 06/08/24 | CO |
SEC Filing 10Q-2 | 06/08/24 | CO |
Slide show half-year results | 06/08/24 | CO |
1st-half-year results | 06/08/24 | CO |
1st quarter results | 08/05/24 | CO |
SEC Filing 10Q-1 | 08/05/24 | CO |
SEC Filing 8K | 08/05/24 | CO |
Annual Report | 07/05/24 | CO |
Proxy Statments | 28/03/24 | CO |
SEC Filing 10K | 13/02/24 | CO |
Annual results | 13/02/24 | CO |
SEC Filing 8K | 13/02/24 | CO |
4th quarter report | 13/02/24 | CO |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition